NICE was heavily criticised when it ruled that patients with rheumatoid arthritis who had failed on one TNF- inhibitor could not use an alternative TNF- inhibitor. However in August 2010, NICE published guidelines that reversed this decision. Dawn Powell summarises the guidelines’ recommendations and Professor Paul Emery talks to Cher Tornhill about the management of rheumatoid arthritis.